References
- Poreba M, Groborz K, Navarro M, et al. Caspase selective reagents for diagnosing apoptotic mechanisms. Cell Death Differ. 2019;26(2):229–244.
- Lee BWL, Ghode P, Ong DST. Redox regulation of cell state and fate. Redox Biol. 2019;25:101056.
- Ao M, Wang K, Zhou X, et al. Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: a potential atheroprotective drug. Pharmacol Res. 2019;148:104445.
- Zhou H, Hu S, Jin Q, et al. Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP opening. J Am Heart Assoc. 2017;6(3):e005328.
- Linkermann A. Death and fire-the concept of necroinflammation. Cell Death Differ. 2019;26(1):1–3.
- Kim YR, Baek JI, Kim SH, et al. Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency. Redox Biol. 2019;20:544–555.
- Guo C, He J, Song X, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res. 2019;149:104463.
- Chen Y, Li S, Guo Y, et al. Astaxanthin attenuates hypertensive vascular remodeling by protecting vascular smooth muscle cells from oxidative stress-induced mitochondrial dysfunction. Oxid Med Cell Longev. 2020;2020:4629189.
- Liang WJ, Gustafsson AB. The aging heart: mitophagy at the center of rejuvenation. Front Cardiovasc Med. 2020;7:18.
- Xiang RL, Huang Y, Zhang Y, et al. Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy. J Cell Physiol. 2020;235(1):232–244.
- Escobar-Henriques M, Joaquim M. Mitofusins: disease gatekeepers and hubs in mitochondrial quality control by E3 ligases. Front Physiol. 2019;10:517.
- He L, Zhou Q, Huang Z, et al. PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions. J Cell Physiol. 2019;234(6):8668–8682.
- Zhou H, Wang S, Hu S, et al. ER-mitochondria microdomains in cardiac ischemia-reperfusion injury: a fresh perspective. Front Physiol. 2018;9:755.
- Motterlini R, Nikam A, Manin S, et al. HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide. Redox Biol. 2019;20:334–348.
- Afonso CB, Spickett CM. Lipoproteins as targets and markers of lipoxidation. Redox Biol. 2019;23:101066.
- Schmidt HM, Kelley EE, Straub AC. The impact of xanthine oxidase (XO) on hemolytic diseases. Redox Biol. 2019;21:101072.
- Zhao Y, Sun J, Zhang W, et al. Follistatin-like 1 protects against doxorubicin-induced cardiomyopathy through upregulation of Nrf2. Oxid Med Cell Longev. 2020;2020:3598715.
- Ji QQ, Li YJ, Wang YH, et al. Salvianolic acid B improves postresuscitation myocardial and cerebral outcomes in a murine model of cardiac arrest: involvement of Nrf2 signaling pathway. Oxid Med Cell Longev. 2020;2020:1605456.
- Chiang S, Huang MLH, Richardson DR. Treatment of dilated cardiomyopathy in a mouse model of Friedreich’s ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis. Pharmacol Res. 2020;159:104994.
- Lei L, Chai Y, Lin H, et al. Dihydroquercetin activates AMPK/Nrf2/HO-1 signaling in macrophages and attenuates inflammation in LPS-induced endotoxemic mice. Front Pharmacol. 2020;11:662.
- Song J, Meng Y, Wang M, et al. Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate. Pharmacol Res. 2020;157:104845.
- Affinito A, Quintavalle C, Esposito CL, et al. The discovery of RNA aptamers that selectively bind glioblastoma stem cells. Mol Ther Nucleic Acids. 2019;18:99–109.
- Hu C, Yang J, Su HY, et al. Yes-associated protein 1 plays major roles in pancreatic stellate cell activation and fibroinflammatory responses. Front Physiol. 2019;10:1467.
- Hu C, Zhang X, Wei W, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019;9(4):690–701.
- Ali AE, Mahdy HM, Elsherbiny DM, et al. Rifampicin ameliorates lithium-pilocarpine-induced seizures, consequent hippocampal damage and memory deficit in rats: impact on oxidative, inflammatory and apoptotic machineries. Biochem Pharmacol. 2018;156:431–443.
- Kadel D, Zhang Y, Sun HR, et al. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy. Cell Biol Toxicol. 2019;35(5):407–421.
- Li G, Liu H, Ma C, et al. Exosomes are the novel players involved in the beneficial effects of exercise on type 2 diabetes. J Cell Physiol. 2019;234(9):14896–14905.
- Chen Z, Ju H, Zhao T, et al. hsa_circ_0092306 targeting miR-197-3p promotes gastric cancer development by regulating PRKCB in MKN-45 cells. Mol Ther Nucleic Acids. 2019;18:617–626.
- Kelly SC, Patel NN, Eccardt AM, et al. Glucose-dependent trans-plasma membrane electron transport and p70S6k phosphorylation in skeletal muscle cells. Redox Biol. 2019;27:101075.
- Liang LP, Pearson-Smith JN, Huang J, et al. Neuroprotective effects of a catalytic antioxidant in a rat nerve agent model. Redox Biol. 2019;20:275–284.
- Fontana G, Martin HL, Lee JS, et al. Mineral-coated microparticles enhance mRNA-based transfection of human bone marrow cells. Mol Ther Nucleic Acids. 2019;18:455–464.
- Sun L, Pang Y, Wang X, et al. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B. 2019;9(4):702–710.
- Sim WC, Kim DG, Lee W, et al. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes (L-serine activates SIRT1 in C2C12 myotubes). Cell Biol Toxicol. 2019;35(5):457–470.
- Bittremieux M, La Rovere RM, Akl H, et al. Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2. Cell Death Differ. 2019;26(3):531–547.
- Kim EH, Wong SW, Martinez J. Programmed necrosis and disease: we interrupt your regular programming to bring you necroinflammation. Cell Death Differ. 2019;26(1):25–40.
- Zhou H, Toan S. Pathological roles of mitochondrial oxidative stress and mitochondrial dynamics in cardiac microvascular ischemia/reperfusion injury. Biomolecules. 2020;10(1):85.
- Wang J, Zhu P, Li R, et al. Bax inhibitor 1 preserves mitochondrial homeostasis in acute kidney injury through promoting mitochondrial retention of PHB2. Theranostics. 2020;10(1):384–397.
- Li RB, Toan S, Zhou H. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging. 2020;12(7):6467–6485.
- Aalto AL, Mohan AK, Schwintzer L, et al. M1-linked ubiquitination by LUBEL is required for inflammatory responses to oral infection in Drosophila. Cell Death Differ. 2019;26(5):860–876.
- Shang X, Lin K, Zhang Y, et al. Mst1 deletion reduces septic cardiomyopathy via activating Parkin-related mitophagy. J Cell Physiol. 2020;235(1):317–327.
- Thai PN, Seidlmayer LK, Miller C, et al. Mitochondrial quality control in aging and heart failure: influence of ketone bodies and mitofusin-stabilizing peptides. Front Physiol. 2019;10:382.
- Yang RM, Tao J, Zhan M, et al. TAMM41 is required for heart valve differentiation via regulation of PINK-PARK2 dependent mitophagy. Cell Death Differ. 2019;26(11):2430–2446.
- Zhou T, Chang L, Luo Y, et al. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol. 2019;21:101120.